44 Studies on Vaccine Efficacy That Raise Doubts on Vaccine Mandates

As some people have now been vaccinated for more than half a year, evidence is pouring in about Covid vaccine efficacy.

When evaluating vaccine efficacy, it is important to distinguish between efficacy against infection, symptomatic disease, and transmission versus efficacy against hospitalization and death. For infection and symptomatic disease, the COVID-19 vaccines are not as efficacious as hoped, with immunity gradually waning after a few months. For hospitalization and death, immunity is stronger, lasting for at least six months.

The gestalt of the findings implies that the infection explosion globally that we have been experiencing—post double vaccination in e.g. Israel, UK, United States, etc.—may be due to the vaccinated spreading Covid as much or more than the unvaccinated.

A natural question to ask is whether vaccines with limited capacity to prevent symptomatic disease may drive the evolution of more virulent strains? In a PLoS Biology article from 2015, Read et al. observed that:

“Conventional wisdom is that natural selection will remove highly lethal pathogens if host death greatly reduces transmission. Vaccines that keep hosts alive but still allow transmission could thus allow very virulent strains to circulate in a population.”

Hence, rather than the unvaccinated putting the vaccinated at risk, it could theoretically be the vaccinated that are putting the unvaccinated at risk, but we have not yet seen any evidence for that.

Here I summarize studies and reports that shed light on vaccine induced immunity against Covid. They highlight the problems with vaccine mandates that are currently threatening the jobs of millions of people. They also raise doubts about the arguments for vaccinating children.

1) Gazit et al. out of Israel showed that “SARS-CoV-2-naïve vaccinees had a 13-fold (95 percent CI, 8-21) increased risk for breakthrough infection with the Delta variant compared to those previously infected.” When adjusting for the time of disease/vaccine, there was a 27-fold increased risk (95 percent CI, 13-57).

2) Ignoring the risk of infection, given that someone was infected, Acharya et al. found “no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta.”

3) Riemersma et al. found “no difference in viral loads when comparing unvaccinated individuals to those who have vaccine “breakthrough” infections. Furthermore, individuals with vaccine breakthrough infections frequently test positive with viral loads consistent with the ability to shed infectious viruses.” Results indicate that “if vaccinated individuals become infected with the delta variant, they may be sources of SARS-CoV-2 transmission to others.” They reported “low Ct values (<25) in 212 of 310 fully vaccinated (68 percent) and 246 of 389 (63 percent) unvaccinated individuals. Testing a subset of these low-Ct samples revealed infectious SARS-CoV-2 in 15 of 17 specimens (88 percent) from unvaccinated individuals and 37 of 39 (95 percent) from vaccinated people.”

4) In a study from Qatar, Chemaitelly et al. reported vaccine efficacy (Pfizer) against severe and fatal disease, with efficacy in the 85-95 percent range at least until 24 weeks after the second dose. As a contrast, the efficacy against infection waned down to around 30 percent at 15-19 weeks after the second dose.

5) From Wisconsin, Riemersma et al. reported that vaccinated individuals who get infected with the Delta variant can transmit SARS-CoV-2 to others. They found an elevated viral load in the unvaccinated and vaccinated symptomatic persons (68 and 69 percent respectively, 158/232 and 156/225). Moreover, in the asymptomatic persons, they uncovered elevated viral loads (29 percent and 82 percent respectively) in the unvaccinated and the vaccinated respectively.

This suggests that the vaccinated can be infected, harbor, cultivate, and transmit the virus readily and unknowingly.

6) Subramanian reported that “at the country-level, there appears to be no discernable relationship between percentage of population fully vaccinated and new COVID-19 cases.” When comparing 2947 counties in the United States, there were slightly less cases in more vaccinated locations. In other words, there is no clear discernable relationship .

7) Chau et al. looked at transmission of SARS-CoV-2 Delta variant among vaccinated healthcare workers in Vietnams. Of 69 healthcare workers that tested positive for SARS-CoV-2, 62 participated in the clinical study, all of whom recovered. For 23 of them, complete-genome sequences were obtained, and all belonged to the Delta variant. “Viral loads of breakthrough Delta variant infection cases were 251 times higher than those of cases infected with old strains detected between March-April 2020”.

8) In Barnstable, Massachusetts, Brown et al found that among 469 cases of COVID-19, 74 percent were fully vaccinated, and that “the vaccinated had on average more virus in their nose than the unvaccinated who were infected.

9) Reporting on a nosocomial hospital outbreak in Finland, Hetemäli et al. observed that “both symptomatic and asymptomatic infections were found among vaccinated health care workers, and secondary transmission occurred from those with symptomatic infections despite use of personal protective equipment.”

10) In a hospital outbreak investigation in Israel, Shitrit et al. observed “high transmissibility of the SARS-CoV-2 Delta variant among twice vaccinated and masked individuals.” They added that “this suggests some waning of immunity, albeit still providing protection for individuals without comorbidities.”

11) In the UK COVID-19 vaccine Surveillance Report for week #42, it was noted that there is “waning of the N antibody response over time” and “that N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination.” The same report (Table 2, page 13), shows the in the older age groups above 30, the double vaccinated persons have greater infection risk than the unvaccinated, presumably because the latter group include more people with stronger natural immunity from prior Covid disease.

As a contrast, the vaccinated people had a lower risk of death than the unvaccinated, across all age groups, indicating that vaccines provide more protection against death than against infection.  See also UK PHE reports 43, 44, 45, 46 for similar data.

12) In Israel, Levin et al. “conducted a 6-month longitudinal prospective study involving vaccinated health care workers who were tested monthly for the presence of anti-spike IgG and neutralizing antibodies”. They found that “six months after receipt of the second dose of the BNT162b2 vaccine, humoral response was substantially decreased, especially among men, among persons 65 years of age or older, and among persons with immunosuppression.”

13) In a study from New York State, Rosenberg et al. reported that “During May 3–July 25, 2021, the overall age-adjusted vaccine effectiveness against hospitalization in New York was relatively stable 89.5–95.1 percent). The overall age-adjusted vaccine effectiveness against infection for all New York adults declined from 91.8 to 75.0 percent.”

14) Suthar et al. noted that “Our data demonstrate a substantial waning of antibody responses and T cell immunity to SARS-CoV-2 and its variants, at 6 months following the second immunization with the BNT162b2 vaccine.”

15) In a study from Umeå University in Sweden, Nordström et al. observed that “vaccine effectiveness of BNT162b2 against infection waned progressively from 92 percent (95 percent CI, 92-93, P<0·001) at day 15-30 to 47 percent (95 percent CI, 39-55, P<0·001) at day 121-180, and from day 211 and onwards no effectiveness could be detected (23 percent; 95 percent CI, -2-41, P=0·07).”

16) Yahi et al. have reported that “in the case of the Delta variant, neutralizing antibodies have a decreased affinity for the spike protein, whereas facilitating antibodies display a strikingly increased affinity. Thus, antibody dependent enhancement may be a concern for people receiving vaccines based on the original Wuhan strain spike sequence.”

17) Goldberg et al. (BNT162b2 Vaccine in Israel) reported that “immunity against the delta variant of SARS-CoV-2 waned in all age groups a few months after receipt of the second dose of vaccine.”

18) Singanayagam et al. examined the transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community. They found that (in 602 community contacts (identified via the UK contract-tracing system) of 471 UK COVID-19 index cases were recruited to the Assessment of Transmission and Contagiousness of COVID-19 in Contacts cohort study and contributed 8145 upper respiratory tract samples from daily sampling for up to 20 days) “vaccination reduces the risk of delta variant infection and accelerates viral clearance. Nonetheless, fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts.”

19) Keehner et al. in NEJM, has recently reported on the resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. Vaccination with mRNA vaccines began in mid-December 2020; by March, 76 percent of the workforce had been fully vaccinated, and by July, the percentage had risen to 87 percent. Infections had decreased dramatically by early February 2021…”coincident with the end of California’s mask mandate on June 15 and the rapid dominance of the B.1.617.2 (delta) variant that first emerged in mid-April and accounted for over 95 percent of UCSDH isolates by the end of July, infections increased rapidly, including cases among fully vaccinated persons…researchers reported that the “dramatic change in vaccine effectiveness from June to July is likely to be due to both the emergence of the delta variant and waning immunity over time.”

20) Juthani et al. sought to describe the impact of vaccination on admission to hospital in patients with confirmed SARS-CoV-2 infection using real-world data collected by the Yale New Haven Health System. “Patients were considered fully vaccinated if the final dose (either second dose of BNT162b2 or mRNA-1273, or first dose of Ad.26.COV2.S) was administered at least 14 days before symptom onset or a positive PCR test for SARS-CoV-2. In total, we identified 969 patients who were admitted to a Yale New Haven Health System hospital with a confirmed positive PCR test for SARS-CoV-2”…Researchers reported “a higher number of patients with severe or critical illness in those who received the BNT162b2 vaccine than in those who received mRNA-1273 or Ad.26.COV2.S…”

To see the other 22 studies, click here: theepochtimes.com

Bold emphasis added

Please Donate Below To Support Our Ongoing Work To Expose The Lies About COVID19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.

Comments (8)

  • Avatar

    ProudUSAGirl

    |

    Our healthcare system is about to experience a tsunami! Potential side effects of jabs include chronic inflammation, because the vaccine continuously stimulates the immune system to produce antibodies. Other concerns include the possible integration of plasmid DNA into the body’s host genome, resulting in mutations, problems with DNA replication, triggering of autoimmune responses, and activation of cancer-causing genes. Alternative COVID cures EXIST. Ivermectin is one of them. While Ivermectin is very effective curing COVID symptoms, it has also been shown to eliminate certain cancers. Do not get the poison jab. If you want to get Ivermectin you can visit https://ivmpharmacy.com

    Reply

    • Avatar

      Wisenox

      |

      EK1 peptide is a pan-fusion inhibitor, but the spikes aren’t all there is to worry about.
      The Moderna patent reads:
      “In one embodiment primary constructs or mmRNA may encode variant polypeptides which have a certain identity with a reference polypeptide sequence. As used herein, a “reference polypeptide sequence” refers to a starting polypeptide sequence. Reference sequences may be wild type sequences or any sequence to which reference is made in the design of another sequence. A “reference polypeptide sequence” may, [b]e.g., be any one of SEQ ID NOs: 1827-3497 as disclosed herein[/b].”
      Its a long list. You can get a spreadsheet showing what each gene is, its function, and associated diseases here:
      Libre file:
      https://drive.protonmail.com/urls/39M2DV6488#yMmIAhc1FcOk
      Excel file:
      https://drive.protonmail.com/urls/DZRCMA4PW8#YqcKpt8BYSoC

      Reply

    • Avatar

      Mark Tapley

      |

      Hello USA:
      No there in No Covid. No purified sample has been verified by any of the world’s health agencies. There is no DNA replication science fiction any more than there are variants of the fake virus. Ivermectin is for deworming cattle (eliminating parasites) and will not effectively treat cancer.

      Reply

  • Avatar

    VOWG

    |

    They don’t work. That is all one needs to know.

    Reply

    • Avatar

      Wisenox

      |

      They work for me.

      Reply

      • Avatar

        Wisenox

        |

        Sorry, I thought you were referring to the links.

        Reply

  • Avatar

    Mark Tapley

    |

    “Vaccines” have never worked. Anytime any population is subjected to this process of injecting contaminated tissue samples made from foreign proteins with nano particles and neuro toxins, the incidence of sickness and death goes way up. No one ever achieved immunity from anything by injecting garbage into their blood stream. Get the truth about the history of “vaccines” in Suzanne Humphries “Dissolving Illusions.:

    Reply

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via